During the past trading week (July 15 to 18), a leading cannabis company in the US announced a blockbuster acquisition plan.

The continued fallout of a non-compliance accusation against a Canadian producer made headlines, and results from a survey on investor and analyst sentiment in the marijuana space also caught attention.


Here’s a closer look at some of the biggest news during last week’s trading period.

CannTrust saga continues to drag for investors

Shareholders of troubled Canadian cannabis producer CannTrust Holdings (NYSE:CTST,TSX:TRST) experienced another tumultuous week of trading following the revelation of the company’s non-compliant facility in Pelham, Ontario.

On Thursday (July 18), BNN Bloomberg reported that CannTrust sources with knowledge have indicated that potential parties are interested in acquiring the assets of CannTrust.

“Such a move could help keep the beleaguered company operating and stave off the worst-case scenario of losing its sales or processing licences as a result of unlicensed production at one of its facilities.”

Shares of the Canadian producer grew in value by nearly 7 percent in New York following the report, and closed on Thursday at a price of US$2.93.

MSO targets US$875 million acquisition

On Wednesday (July 17), multi-state operator (MSO) Curaleaf Holdings (CSE:CURA,OTCQX:CURLF) announced the US$875 million purchase of a private cannabis company, GR Companies, with retail and cultivation assets in the US.

The combined company will manage 131 dispensary licenses, 68 physical locations, 20 cultivation sites and 26 processing facilities.

“In every important state, (Curaleaf has) assets now that are operational and generating revenues … whereas in some instances, other competitors have license holdings in certain states, but don’t don’t have anything operational,” said Robert Fagan, an analyst with GMP Securities covering the MSO.

Shares of Curaleaf jumped by double digits in value on Wednesday following the acquisition announcement.

Market updates

As part of its quarterly survey on investment market sentiment, Horizons ETFs Management (Canada) revealed that both investors and analysts have turned on cannabis stocks.

“It may still be too early to say that the Marijuana sector’s post-legalization afterglow has come to an end, but it’s becoming apparent that it has lost some of its ‘shine,’ particularly among hard-won advisors,” said Steve Hawkins, president and CEO of Horizons ETFs.

According to the survey, bullish sentiment for cannabis stocks fell to 58 percent of investor respondents and to 36 percent for advisors of the space, compared to a respective 70 and 40 percent previously.

With an initial public offering (IPO) worth US$575 million, Subversive Capital Acquisition (SCAC) (NEO:SVC.UN.U) made its trading debut on the NEO Exchange in Canada. The company was the fifth SPAC to list on the NEO.

According to exchange regulators, the debut from SCAC represents the biggest IPO for a SPAC. The company will target acquisitions in the cannabis industry, but will not be limited to this sector.

“We’re looking at what is the largest, regardless of industry or sector … SPAC that’s ever been listed in Canada, and I think that is a token about the interest and appetite in this industry and the opportunity it represents,” Jos Schmitt, CEO of the Canadian exchange, told the Investing News Network.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less